5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid

C16H26N2O9S — CID 140584498

IUPAC5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid
SMILESO=C(O)CCCC[C@H]1SC[C@H]2NC(=O)N(C(O)[C@H]3O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]3O)[C@H]21
InChIInChI=1S/C16H26N2O9S/c19-8(20)4-2-1-3-7-9-6(5-28-7)17-16(26)18(9)14(24)13-11(22)10(21)12(23)15(25)27-13/h6-7,9-15,21-25H,1-5H2,(H,17,26)(H,19,20)/t6-,7-,9-,10+,11+,12+,13+,14?,15+/m1/s1
InChIKeyBNHRHZINRINTOE-INJMULIESA-N
MW422.46 g/mol
LogP-2.37
Rot. Bonds7

About 5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid

5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid (PubChem CID 140584498) has the molecular formula C16H26N2O9S and a molecular weight of 422.46 g/mol. Its IUPAC name is 5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid.

Molecular Properties

Compound Name5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid
PubChem CID140584498
Molecular FormulaC16H26N2O9S
Molecular Weight422.46 g/mol
Exact Mass422.14
IUPAC Name5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid
SMILESO=C(O)CCCC[C@H]1SC[C@H]2NC(=O)N(C(O)[C@H]3O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]3O)[C@H]21
InChIInChI=1S/C16H26N2O9S/c19-8(20)4-2-1-3-7-9-6(5-28-7)17-16(26)18(9)14(24)13-11(22)10(21)12(23)15(25)27-13/h6-7,9-15,21-25H,1-5H2,(H,17,26)(H,19,20)/t6-,7-,9-,10+,11+,12+,13+,14?,15+/m1/s1
InChIKeyBNHRHZINRINTOE-INJMULIESA-N
XLogP-2.37
TPSA180.02 Ų
H-Bond Donors7
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms28
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500422.46
LogP ≤ 5-2.37
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'biotin_analogue', 'substructure': 'N/A'}

Analyze 5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid?
The IUPAC name of 5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid (CID 140584498) is 5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid.
What is the SMILES notation for 5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid?
The canonical SMILES for 5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid is O=C(O)CCCC[C@H]1SC[C@H]2NC(=O)N(C(O)[C@H]3O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]3O)[C@H]21.
What is the InChIKey of 5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid?
The InChIKey is BNHRHZINRINTOE-INJMULIESA-N. The full InChI is InChI=1S/C16H26N2O9S/c19-8(20)4-2-1-3-7-9-6(5-28-7)17-16(26)18(9)14(24)13-11(22)10(21)12(23)15(25)27-13/h6-7,9-15,21-25H,1-5H2,(H,17,26)(H,19,20)/t6-,7-,9-,10+,11+,12+,13+,14?,15+/m1/s1.
What are the key properties of 5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid?
5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid has a molecular weight of 422.46 g/mol, XLogP of -2.37, 7 rotatable bonds, 7 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(3aR,4R,6aS)-3-[hydroxy-[(2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid is sourced from PubChem (CID 140584498), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).